Return
Sensitive Sequencing method for KRAS mutation detection by pyrosequencing
DOI:10.1016/S1525-1578(10)60571-5.png)
Abstract
En 中文
Both benign and malignant tumors represent heterogenous tissue containing tumor cells and non-neoplastic mesenchymal and inflammatory cells. To detect a minority of mutant KRAS alleles among abundant wild-type alleles, we developed a sensitive DNA sequencing assay using Pyrosequencing, ie, nucleotide extension sequencing with an allele quantification capability. We designed our Pyrosequencing assay for use with whole-genome-amplified DNA from paraffin-embedded tissue. Assessing various mixtures of DNA from mutant KRAS cell lines and DNA from a wild-type KRAS cell line, we found that mutation detection rates for Pyrosequencing were superior to dideoxy sequencing. In addition, Pyrosequencing proved superior to dideoxy sequencing in the detection of KRAS mutations from DNA mixtures of paraffin-embedded colon cancer and normal tissue as well as from paraffin-embedded pancreatic cancers. Quantification of mutant alleles by Pyrosequencing was precise and useful for assay validation, monitoring, and quality assurance. Our Pyrosequencing method is simple, robust, and sensitive, with a detection limit of approximately 5% mutant alleles. It is particularly useful for tumors containing abundant non-neoplastic cells. In addition, the applicability of this assay for DNA amplified by whole-genome amplification technique provides an expanded source of DNA for large-scale studies.
Keywords:
K-RAS MUTATIONS
SINGLE NUCLEOTIDE POLYMORPHISM
WHOLE-GENOME AMPLIFICATION
POINT MUTATIONS
DNA
CANCER
TUMORS
QUANTIFICATION
DIAGNOSIS
ARRAY
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.4
Papers:
2.3K
Citations:
5.3K
Organization
No organization information available
Cited Papers
Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis
NUCLEIC ACIDS RESEARCH
IF13.1
Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype
JOURNAL OF PATHOLOGY
IF5.2

